106 related articles for article (PubMed ID: 31608670)
1. Parenterial iron sucrose-induced renal preconditioning: differential ferritin heavy and light chain expression in plasma, urine, and internal organs.
Johnson AC; Gooley T; Guillem A; Keyser J; Rasmussen H; Singh B; Zager RA
Am J Physiol Renal Physiol; 2019 Dec; 317(6):F1563-F1571. PubMed ID: 31608670
[TBL] [Abstract][Full Text] [Related]
2. Iron sucrose ('RBT-3') activates the hepatic and renal HAMP1 gene, evoking renal hepcidin loading and resistance to cisplatin nephrotoxicity.
Zager RA; Johnson ACM; Therapeutics R
Nephrol Dial Transplant; 2021 Feb; 36(3):465-474. PubMed ID: 33547792
[TBL] [Abstract][Full Text] [Related]
3. A Pharmacologic "Stress Test" for Assessing Select Antioxidant Defenses in Patients with CKD.
Zager RA; Johnson ACM; Guillem A; Keyser J; Singh B
Clin J Am Soc Nephrol; 2020 May; 15(5):633-642. PubMed ID: 32291269
[TBL] [Abstract][Full Text] [Related]
4. Oxidant- induced preconditioning: A pharmacologic approach for triggering renal 'self defense'.
Zager RA
Physiol Rep; 2022 Oct; 10(20):e15507. PubMed ID: 36305701
[TBL] [Abstract][Full Text] [Related]
5. Combined iron sucrose and protoporphyrin treatment protects against ischemic and toxin-mediated acute renal failure.
Zager RA; Johnson AC; Frostad KB
Kidney Int; 2016 Jul; 90(1):67-76. PubMed ID: 27165818
[TBL] [Abstract][Full Text] [Related]
6. Parenteral iron nephrotoxicity: potential mechanisms and consequences.
Zager RA; Johnson AC; Hanson SY
Kidney Int; 2004 Jul; 66(1):144-56. PubMed ID: 15200421
[TBL] [Abstract][Full Text] [Related]
7. Elevated levels of ferritin in the cerebrospinal fluid of amyotrophic lateral sclerosis patients.
Zheng Y; Gao L; Wang D; Zang D
Acta Neurol Scand; 2017 Aug; 136(2):145-150. PubMed ID: 27804118
[TBL] [Abstract][Full Text] [Related]
8. Identification of H ferritin-dependent and independent genes in K562 differentiating cells by targeted gene silencing and expression profiling.
Misaggi R; Di Sanzo M; Cosentino C; Bond HM; Scumaci D; Romeo F; Stellato C; Giurato G; Weisz A; Quaresima B; Barni T; Amato F; Viglietto G; Morrone G; Cuda G; Faniello MC; Costanzo F
Gene; 2014 Feb; 535(2):327-35. PubMed ID: 24239552
[TBL] [Abstract][Full Text] [Related]
9. Morphine-Induced Modulation of Endolysosomal Iron Mediates Upregulation of Ferritin Heavy Chain in Cortical Neurons.
Nash B; Tarn K; Irollo E; Luchetta J; Festa L; Halcrow P; Datta G; Geiger JD; Meucci O
eNeuro; 2019; 6(4):. PubMed ID: 31300544
[TBL] [Abstract][Full Text] [Related]
10. The cellular transformation of injected colloidal iron complexes into ferritin and hemosiderin in experimental animals; a study with the aid of electron microscopy.
RICHTER GW
J Exp Med; 1959 Feb; 109(2):197-216. PubMed ID: 13620849
[TBL] [Abstract][Full Text] [Related]
11. Worsening Renal Function in Patients With Acute Heart Failure Undergoing Aggressive Diuresis Is Not Associated With Tubular Injury.
Ahmad T; Jackson K; Rao VS; Tang WHW; Brisco-Bacik MA; Chen HH; Felker GM; Hernandez AF; O'Connor CM; Sabbisetti VS; Bonventre JV; Wilson FP; Coca SG; Testani JM
Circulation; 2018 May; 137(19):2016-2028. PubMed ID: 29352071
[TBL] [Abstract][Full Text] [Related]
12. Heart protection by ischemic preconditioning: a novel pathway initiated by iron and mediated by ferritin.
Chevion M; Leibowitz S; Aye NN; Novogrodsky O; Singer A; Avizemer O; Bulvik B; Konijn AM; Berenshtein E
J Mol Cell Cardiol; 2008 Dec; 45(6):839-45. PubMed ID: 18817783
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms and consequences of oxidant-induced renal preconditioning: an Nrf2-dependent, P21-independent, anti-senescence pathway.
Johnson ACM; Zager RA
Nephrol Dial Transplant; 2018 Nov; 33(11):1927-1941. PubMed ID: 29522116
[TBL] [Abstract][Full Text] [Related]
14. Alterations in cellular Ca(2+) and free iron pool by sulfur amino acid deprivation: the role of ferritin light chain down-regulation in prooxidant production.
Kim HJ; Kim SG
Biochem Pharmacol; 2002 Feb; 63(4):647-57. PubMed ID: 11992632
[TBL] [Abstract][Full Text] [Related]
15. Failure of remote ischemic preconditioning to reduce the risk of postoperative acute kidney injury in children undergoing operation for complex congenital heart disease: a randomized single-center study.
Pedersen KR; Ravn HB; Povlsen JV; Schmidt MR; Erlandsen EJ; Hjortdal VE
J Thorac Cardiovasc Surg; 2012 Mar; 143(3):576-83. PubMed ID: 21955475
[TBL] [Abstract][Full Text] [Related]
16. Parenteral iron treatment induces MCP-1 accumulation in plasma, normal kidneys, and in experimental nephropathy.
Zager RA
Kidney Int; 2005 Oct; 68(4):1533-42. PubMed ID: 16164630
[TBL] [Abstract][Full Text] [Related]
17. Urinary vanin-1 as a novel biomarker for early detection of drug-induced acute kidney injury.
Hosohata K; Ando H; Fujimura A
J Pharmacol Exp Ther; 2012 Jun; 341(3):656-62. PubMed ID: 22399813
[TBL] [Abstract][Full Text] [Related]
18. Renal function in patients with non-dialysis chronic kidney disease receiving intravenous ferric carboxymaltose: an analysis of the randomized FIND-CKD trial.
Macdougall IC; Bock AH; Carrera F; Eckardt KU; Gaillard C; Van Wyck D; Meier Y; Larroque S; Roger SD;
BMC Nephrol; 2017 Jan; 18(1):24. PubMed ID: 28095881
[TBL] [Abstract][Full Text] [Related]
19. H-ferritin ferroxidase induces cytoprotective pathways and inhibits microvascular stasis in transgenic sickle mice.
Vercellotti GM; Khan FB; Nguyen J; Chen C; Bruzzone CM; Bechtel H; Brown G; Nath KA; Steer CJ; Hebbel RP; Belcher JD
Front Pharmacol; 2014; 5():79. PubMed ID: 24860503
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil gelatinase-associated lipocalin: a novel early urinary biomarker for cisplatin nephrotoxicity.
Mishra J; Mori K; Ma Q; Kelly C; Barasch J; Devarajan P
Am J Nephrol; 2004; 24(3):307-15. PubMed ID: 15148457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
